STRATA Skin Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of STRATA Skin Sciences generated cash of -$519,000, which is more than the previous year. Cash used in financing activities reached the amount of $6,861,000 last year. Net change in cash is therefore $1,323,000.
Cash Flow
| 2014 | -17.70M | 17K | 25.34M |
|---|---|---|---|
| 2015 | -6.58M | -44.22M | 42.67M |
| 2016 | 322K | -868K | 1.16M |
| 2017 | 4.14M | -2.19M | -1.80M |
| 2018 | 2.89M | -1.78M | 11.30M |
| 2019 | 2.22M | -2.79M | -296K |
| 2020 | 2.09M | -2.15M | 2.54M |
| 2021 | 1.50M | -7.12M | 92K |
| 2022 | -1.10M | -4.18M | -500K |
| 2023 | -519K | -5.01M | 6.86M |
SSKN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 6.79M | 12.58M | 18.11M | 15.62M | 16.48M | 4.06M | 3.92M | 3.30M | 11.43M | 3.78M |
Operating activities | ||||||||||
Net income | -10.83M | -5.54M | -2.70M | -4.41M | -3.79M | -4.03M | -18.83M | -3.33M | -24.94M | -14.14M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.90M | 5.68M | 4.08M | 3.91M | 4.82M | 5.39M | 6.33M | 6.36M | 4.05M | 1.79M |
Stock-based compensation expense | 1.30M | 1.46M | 1.64M | 1.63M | 1.19M | 0 | 186K | 113K | 1.75M | 413K |
| Deferred income tax benefit | 1.30M | 1.46M | 1.64M | 1.63M | 1.19M | 0 | 186K | 113K | 1.75M | 413K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 141K | -1.14M | -490K | 1.35M | -1.03M | -222K | 184K | 558K | -186K | -215K |
Inventories | 689K | -1.52M | -45K | -417K | -233K | 215K | -193K | 1.31M | -508K | -784K |
Accounts payable | -100K | 603K | 58K | 884K | 116K | -513K | 381K | -2.60M | 542K | -241K |
Cash generated by operating activities | -519K | -1.10M | 1.50M | 2.09M | 2.22M | 2.89M | 4.14M | 322K | -6.58M | -17.70M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -5.01M | -3.55M | -3.65M | -2.15M | -2.79M | -1.76M | -1.73M | -1.00M | -1.68M | 0 |
Acquisitions Net | 0 | -631K | -3.47M | 0 | 0 | 0 | 0 | 125K | -42.5M | 0 |
Cash generated by investing activities | -5.01M | -4.18M | -7.12M | -2.15M | -2.79M | -1.78M | -2.19M | -868K | -44.22M | 17K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 18K | 0 | 17M | 0 | 0 | 0 | 11.45M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 6.90M | 0 | -7.77M | -2.52M | -296K | -3.35M | -1.80M | -333K | 42.80M | -15M |
Cash used in financing activities | 6.86M | -500K | 92K | 2.54M | -296K | 11.30M | -1.80M | 1.16M | 42.67M | 25.34M |
Net Change In Cash | 1.32M | -5.79M | -5.52M | 2.48M | -858K | 12.41M | 141K | 625K | -8.13M | 7.65M |
Cash at end of period | 8.11M | 6.79M | 12.58M | 18.11M | 15.62M | 16.48M | 4.06M | 3.92M | 3.30M | 11.43M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |